Evidence map›Paper›PMID 26439917›Full record

ReviewCurrent HIV/AIDS reports2015

Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.

Jeffrey I Campbell, Jessica E Haberer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Advancing the Science and Practice of Medication Adherence.Journal of general internal medicine · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeffrey I CampbellMassachusetts General Hospital Center for Global Health, 125 Nashua Street, Suite 722, Boston, MA, 02114, USA.
Jessica E HabererMassachusetts General Hospital Center for Global Health, 125 Nashua Street, Suite 722, Boston, MA, 02114, USA. jhaberer@mgh.harvard.edu.
Center for Global Health · US

Funding

Development of Real-Time Antiretroviral Therapy Adherence Intervention in UgandaR34MH100940 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2013 to 2015
$593k
The ethics of electronic adherence monitoring for HIV research and care in UgandaR21AI108329 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI EYAL, NIR, HABERER, JESSICA ELIZABETH · 2013 to 2014
$411k
NIAID NIH HHS R21 AI108329NIAID NIH HHS R21AI108329NIMH NIH HHS R34 MH100940PHS HHS R34H100940
6 · The paper itself

Abstract

Numerous cell phone-based and adherence monitoring technologies have been developed to address barriers to effective HIV prevention, testing, and treatment. Because most people living with HIV and AIDS reside in resource-limited settings (RLS), it is important to understand the development and use of these technologies in RLS. Recent research on cell phone-based technologies has focused on HIV education, linkage to and retention in care, disease tracking, and antiretroviral therapy adherence reminders. Advances in adherence devices have focused on real-time adherence monitors, which have been used for both antiretroviral therapy and pre-exposure prophylaxis. Real-time monitoring has recently been combined with cell phone-based technologies to create real-time adherence interventions using short message service (SMS). New developments in adherence technologies are exploring ingestion monitoring and metabolite detection to confirm adherence. This article provides an overview of recent advances in these two families of technologies and includes research on their acceptability and cost-effectiveness when available. It additionally outlines key challenges and needed research as use of these technologies continues to expand and evolve.

Indexed as

Text MessagingAnti-HIV AgentsHIV InfectionsHumansMedication AdherenceSocioeconomic FactorsAnti-HIV AgentsCell phonesElectronic adherence monitoringHIV antiretroviral therapyTechnology

Identifiers

PMID26439917
OpenAlexW1894802824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.